Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$75,686
-$245,811 QoQ
Shares Held
41,816
-78.8% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SummitTX Capital, L.P. holds $177,432,917 across 62 Biotechnology names. OCGN ranks #52 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
165,599 | $14,402,145 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
73,222 | $13,842,619 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
36,838 | $11,868,835 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
293,780 | $11,307,592 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
|
995,885 | $11,064,282 | |
| 6 | INBX |
Inhibrx Biosciences, Inc.
|
137,821 | $9,265,705 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
100,044 | $8,395,692 | |
| 8 | ZYME |
Zymeworks Inc.
|
321,427 | $8,048,532 |
All Filings in OCGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $75,686 | 41,816 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $321,497 | 197,238 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $620,024 | 639,200 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||